SEC 13F Intelligence

Farallon Capital Management, L.L.C. / BBIO

Farallon Capital Management, L.L.C.’s Bridgebio Pharma Inc Position

Does Farallon Capital Management, L.L.C. own Bridgebio Pharma Inc (BBIO)? Yes — 9.37M shares worth $695M (+3.77% of its 13F portfolio) as of Q1 2026, up from 9.00M shares the prior filed quarter.

Position Value
$695M
Q1 2026
Shares
9.37M
% of Portfolio
+3.77%
Quarters Held
8
currently held

Position History BBIO

Reported value by quarter
Q4 ’23: $242,220Q4 ’23Q3 ’24: $44MQ3 ’24Q4 ’24: $115MQ4 ’24Q1 ’25: $198MQ1 ’25Q2 ’25: $341MQ2 ’25Q3 ’25: $425MQ3 ’25Q4 ’25: $688MQ4 ’25Q1 ’26: $695MQ1 ’26filingsflow.com
QuarterSharesValue% of Portfolio
Q1 20269.37M$695M+3.77%
Q4 20259.00M$688M+3.25%
Q3 20258.19M$425M+1.74%
Q2 20257.90M$341M+1.44%
Q1 20255.73M$198M+1.06%
Q4 20244.20M$115M+0.58%
Q3 20241.75M$44M+0.22%
Q4 20236.0K$242,2200.00%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Farallon Capital Management, L.L.C.’s full portfolio or all institutional holders of BBIO.